AIM hosted the Annual Influenza Update and Communications Training webinar on September 20, 2022, and discussed what to expect this upcoming influenza season.
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.
As the "new kid on the block," Heather Burris shares her learnings and challenges from her freshman year of being an immunization manager in episode three.
The Translating Vaccine Confidence Research into Practice webinar provided immunization programs tools to help increase vaccine confidence in their communities.
This COVID-19 Test to Treat handout was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the Test to Treat program for COVID-19 disease.
Activity has slowed as remaining legislative sessions come to a close. Through the summer, AIM staff will compile new or moving legislation in jurisdictions.